GIVING A GLOBAL COMPANY A SINGLE VIEW OF THE TRUTH
We worked with this top 10 global pharmaceutical company to provide a single view of the worldwide market across the organization.
Global pharmaceutical companies are complex, distributed organizations, with many different stakeholders each with their own view of performance. The multiple versions of the truth were leading to disjointed strategy and difficulties identifying the business’s priorities. These problems were compounded by a 40% cut in analyst numbers – and expanding reporting requirements.
FINDING THE TIME TO IDENTIFY INSIGHTS
A top 10 global pharmaceutical company was struggling to cope with multiple US data sources. Our specially developed platform took over the data management, giving them back vital time.
This pharma giant’s US analytics team was pulling together six to eight data sources each week in order to attempt to understand their performance and the behavior of competitors in this sophisticated and complicated market. All their time was taken on data preparation, leaving little time for thinking and insights, and even then reporting outputs were at times inconsistent.
HARMONIZING A HIGHLY FRAGMENTED PICTURE
We helped a top 20 global pharmaceutical company find the best approach to understand the complicated and confusing oncology market.
Our client had been reporting on 10 different cancer types, but now management wanted insights on 40 cancer types – with no additional headcount. The team needed to manage five data sources to understand the market, and each data source had a different front end. They were drowning under the demands of data preparation and manual reporting.
A GLOBAL VIEW OF ANALYTICS BY SPECIES
We provided a top 10 animal health company with a common global platform upon which to build detailed analytics by species.
The global sales data source was being manipulated by through a series of Excel spreadsheets, with business rules and algorithms added at source. This was becoming unsustainable as the business was expanding, as it limited the ability of others around the organization to see a consolidated view of the business.
GIVING ANALYSTS BACK TIME TO ANALYZE
A top 20 global pharmaceutical company had no common global/regional data set for their consumer health market. We used our knowledge of consumer product datasets to give them a single consolidated picture.
Understanding and analyzing the patterns of behavior in the consumer health market is not an easy ask. Data is distributed among many different country level vendors and affiliates and our client was spending massive amounts of time on data preparation and manual reporting.